Rajko Kušec

3.2k total citations
104 papers, 2.0k citations indexed

About

Rajko Kušec is a scholar working on Genetics, Hematology and Molecular Biology. According to data from OpenAlex, Rajko Kušec has authored 104 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Genetics, 42 papers in Hematology and 41 papers in Molecular Biology. Recurrent topics in Rajko Kušec's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (33 papers), Acute Myeloid Leukemia Research (26 papers) and Lymphoma Diagnosis and Treatment (20 papers). Rajko Kušec is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (33 papers), Acute Myeloid Leukemia Research (26 papers) and Lymphoma Diagnosis and Treatment (20 papers). Rajko Kušec collaborates with scholars based in Croatia, United Kingdom and Austria. Rajko Kušec's co-authors include Jacqueline Boultwood, James S. Wainscoat, Philip Beer, Claire Harrison, Anthony R. Green, Branimir Jakšić, Vlatko Pejša, Carrie Fidler, Marko Lucijanić and Klaus Laczika and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Rajko Kušec

99 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rajko Kušec Croatia 24 1.0k 979 887 341 280 104 2.0k
Toshiko Motoji Japan 26 1.5k 1.5× 915 0.9× 700 0.8× 259 0.8× 578 2.1× 121 2.6k
Angelo Guerrasio Italy 24 938 0.9× 787 0.8× 547 0.6× 159 0.5× 255 0.9× 105 1.7k
Detlef Haase Germany 23 2.4k 2.4× 1.0k 1.1× 1.1k 1.2× 274 0.8× 346 1.2× 101 3.1k
Erica Travaglino Italy 20 2.0k 1.9× 488 0.5× 1.3k 1.4× 201 0.6× 253 0.9× 57 2.3k
Carlos Bueso-Ramos United States 18 1.0k 1.0× 750 0.8× 572 0.6× 192 0.6× 208 0.7× 37 1.7k
Thomas Cluzeau France 20 1.4k 1.4× 808 0.8× 569 0.6× 151 0.4× 309 1.1× 107 2.0k
Peter Browett New Zealand 22 724 0.7× 453 0.5× 442 0.5× 333 1.0× 508 1.8× 91 1.7k
David Joske Australia 20 906 0.9× 741 0.8× 809 0.9× 774 2.3× 634 2.3× 45 2.6k
Norifumi Tsukamoto Japan 25 826 0.8× 381 0.4× 561 0.6× 706 2.1× 433 1.5× 139 2.1k
Benet Nomdedeu Spain 22 881 0.9× 361 0.4× 829 0.9× 592 1.7× 349 1.2× 88 1.8k

Countries citing papers authored by Rajko Kušec

Since Specialization
Citations

This map shows the geographic impact of Rajko Kušec's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rajko Kušec with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rajko Kušec more than expected).

Fields of papers citing papers by Rajko Kušec

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rajko Kušec. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rajko Kušec. The network helps show where Rajko Kušec may publish in the future.

Co-authorship network of co-authors of Rajko Kušec

This figure shows the co-authorship network connecting the top 25 collaborators of Rajko Kušec. A scholar is included among the top collaborators of Rajko Kušec based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rajko Kušec. Rajko Kušec is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lucijanić, Marko, et al.. (2025). Extreme Thrombocytosis in Patients with Overt Myelofibrosis and Its Clinical Associations. Cancers. 17(9). 1390–1390.
2.
Lucijanić, Marko, et al.. (2024). Secondary polycythemia in acutely ill COVID-19 patients is associated with higher mortality but not markedly higher thrombotic risk. Scandinavian Journal of Clinical and Laboratory Investigation. 84(2). 84–90. 1 indexed citations
3.
4.
5.
Heibl, Sonja, Bettina Gisslinger, Peter Bettelheim, et al.. (2020). Clinical, Hematologic, Biologic and Molecular Characteristics of Patients with Myeloproliferative Neoplasms and a Chronic Myelomonocytic Leukemia-Like Phenotype. Cancers. 12(7). 1891–1891. 4 indexed citations
6.
Lucijanić, Marko, et al.. (2020). C reactive protein to albumin ratio as prognostic marker in primary and secondary myelofibrosis. Leukemia & lymphoma. 61(12). 2969–2974. 6 indexed citations
7.
Radman, Ivo, Jelena Roganović, Duška Petranović, et al.. (2019). Croatian Hematology Society and CROHEM guidelines for the treatment of iron deficiency anemia. Hrčak Portal of scientific journals of Croatia (University Computing Centre). 141(1-2). 1–13. 2 indexed citations
8.
Kušec, Rajko, et al.. (2018). Neck adipose tissue – tying ties in metabolic disorders. Hormone Molecular Biology and Clinical Investigation. 33(2). 24 indexed citations
9.
Lucijanić, Marko, Dario Rahelić, Vlatko Pejša, et al.. (2018). Assessing serum albumin concentration, lymphocyte count and prognostic nutritional index might improve prognostication in patients with myelofibrosis. Wiener klinische Wochenschrift. 130(3-4). 126–133. 30 indexed citations
10.
11.
Lucijanić, Marko, Zdravko Mitrović, Vlatko Pejša, et al.. (2017). Increased mean platelet volume (MPV) is an independent predictor of inferior survival in patients with primary and secondary myelofibrosis. International Journal of Hematology. 107(2). 166–172. 9 indexed citations
12.
Mitrović, Zdravko, et al.. (2015). [The use of peripherally inserted central catheter (PICC) in patients with hematological malignancies--a single center experience].. PubMed. 136(5-6). 136–40. 5 indexed citations
13.
Mitrović, Zdravko, et al.. (2014). Upotreba periferno uvedenoga centralnog venskog katetera (PICC) u bolesnika sa zloćudnim hematološkim bolestima - prikaz vlastitih iskustava [The use of peripherally inserted central catheter (PICC) in patients with hematological malignancies - a single center experience]. Repository of the Medical Faculty of the University of Zagreb (University of Zagreb). 1 indexed citations
14.
Labar, Boris, et al.. (2010). DIJAGNOSTIČKO-TERAPIJSKI PRISTUP U BOLESNIKA S ESENCIJALNOM TROMBOCITEMIJOM Smjernice Hrvatske kooperativne grupe za hematološke bolesti – KROHEM. University of Zagreb University Computing Centre (SRCE). 132. 0–0.
15.
Pejša, Vlatko, et al.. (2004). Rapid decrease in high titer of factor VIII inhibitors upon immunosuppressive treatment in severe postpartum acquired hemophilia A.. PubMed. 45(2). 213–6. 4 indexed citations
16.
Flegar-Meštrić, Zlata, et al.. (2004). Učestalost molekularnih izoformi Bcr/Abl p210 i njihovo kliničko značenje u bolesnika s kroničnom mijeloičnom leukemijom. Biochemia Medica. 14. 37–45.
17.
Kušec, Rajko, et al.. (2004). FMS-LIKE TYROSINE KINASE (FLT3) GENE ITD MUTATION IN ACUTE MYELOID LEUKEMIA. SHILAP Revista de lepidopterología. 73(1). 5–7. 2 indexed citations
18.
Daly, Sarah B., J. S. Wainscoat, Elaine R. Levy, et al.. (2001). Physical and transcriptional characterization of the commonly deleted region in del(9q) AML.. Blood. 98. 1 indexed citations
19.
Atoyebi, Wale, et al.. (1997). Glutathione S-transferase theta 1 (GSTT1) gene defect in myelodysplasia and acute myeloid leukaemia. The Lancet. 349. 1450–1451. 1 indexed citations
20.
Boultwood, Jacqueline, Carrie Fidler, Ken Mills, et al.. (1996). Amplification of mitochondrial DNA in acute myeloid leukaemia. British Journal of Haematology. 95(2). 426–431. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Toshiko Motoji Breakdown of academic impact, for papers by Angelo Guerrasio Breakdown of academic impact, for papers by Detlef Haase Breakdown of academic impact, for papers by Erica Travaglino Breakdown of academic impact, for papers by Carlos Bueso-Ramos Breakdown of academic impact, for papers by Thomas Cluzeau Breakdown of academic impact, for papers by Peter Browett Breakdown of academic impact, for papers by David Joske Breakdown of academic impact, for papers by Norifumi Tsukamoto Breakdown of academic impact, for papers by Benet Nomdedeu
Rankless by CCL
2026